-
1 . Academic Journal
Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial
- 저자
- by BABA-HAMED, Nabil; BABIN, Emmanuel; BERA, Guillaume; BETRIAN-LAGARDE, Sarah; BLOT, Emmanuel, et al.
- 소스
- In The Lancet Oncology April 2021 22(4):463-475